AstraZeneca PLC (AZN)

8,191.0
-40.0(-0.49%)
  • Volume:
    1,630,389
  • Bid/Ask:
    8,045.0/9,000.0
  • Day's Range:
    8,098.0 - 8,261.0

AZN Comments

What is your sentiment on AstraZeneca PLC?
or
Market is currently closed. Voting is open during market hours.

All Comments

(76)
  • I thought it would completely collapse like 10%. But looking at the chart and PE, this has already pulled back to before covid.
    1
    • Unlikely as the data doesn’t supoort the coutries citing thrombrosis issues as the numbers are far less than occur normally in the community. Its just everything is being blamed on vaccines....next we will see is a flat tyre being blamed on vaccine 🤪
      1
    • Simon Morris  It's true, I had a flat tyre and I found out that it was the vaccine. So until I see proof that it wasn't the vaccine I am going to ride around on steel rims/hubs. It has got to be better than using that horrible old vaccine.  Europeans eh? Cant live with them can live without them. I can say that because my wife is Italian :) Actually let me just go and check that with her.
      1
    • Peter kurbe nice to your good lady or she might cut off the chianti 👀🤭😆
      1
  • 6000 is coming, time to short
    4
    • It's become gambling at this moment to try and predict the price movement. It is true that there are some apparent issues with their vaccines, but I expect them to sort it all out in a matter of weeks. Also, it is not like people are massively dying because of their vaccine - that would be really troublesome and would most certainly cause a bigger price collapse.
      0
  • This will go down more, Issues with Astrazenica Oxford Vaccines.
    1
    • There are no issues or we’d see numbers far in excess of the normal levels in the community. If anything the cases of clots are a lot less than occur normally 🤷🏼‍♂️
      0
  • Is Azn worth buying at this price or is there going to be a further drop?
    2
    • 03/03/21 Astrazeneca: Deutsche Bank reiterates buy with a target price of 10,000p.
      1
      • Is it still worth keeping AZN, when is the divident and how much it would be
        0
        • As I said in Jan this will touch 7000 and here we are. If it goes below then 6700 is the next stop
          2
          • 6700 is coming very soon
            0
          • thanks what the reason for weakness ?
            0
        • If i purchase the stock today, will i get the dividend?
          2
          • yes it goes ex div today 25th
            1
          • if u bought on 24th feb, u would have made a loss, the yield wouldn't cover the capital loss. Looks bearish until next support.
            0
        • The 2 charges they currently have will seriously affect the share price, l would consider buying back in if its around 6200
          5
          • What changes?
            0
        • AstraZeneca to sell its holding in Viela Bio
          1
          • How would that effect share holders
            1
        • At least. COVAX to send AstraZeneca shot to Latin America. https://www.reuters.com/article/us-health-coronavirus-vaccines-latam-idUSKBN2A11UD
          1
          • Despite the high demand why its going down
            2
            • Its overpriced at the moment
              0
          • Going back to 7200, possibily 7000
            3
            • https://www.cnbc.com/2021/01/21/bofa-picks-astrazeneca-azn-and-other-european-stocks-for-the-decade-.html
              1
              • Analysts from Bank of America have listed their top European stocks for the next 10 years. AZN is their top pick
                3
                • It is definitely buy, wants a one push to get momentum, I think today's push a step forward in that direction. Demand will improve & we may see a great earning in Q4 quarter
                  0
                  • This looks weak, time to short it
                    3
                    • Try it
                      1
                  • How come this stock rose on LSE while it fell on TradeGate (both today)?
                    0
                    • India approves AZN after UK and Brazil, rest of the world just sitting on the fence and would approve soon. UK has reaffirmed its global leadership on pharmaceuticals, AZN leading the way
                      0
                      • Why GSK performing better than AZN suddenly??
                        0
                        • Sold out today. If good news like that cant lift the share price then I dont know what will. May buy back in below 7000, which I believe its heading there
                          0
                          • A bit premature to exit, i would have waited for Q1 results
                            0
                          • covid vaccination is a zero profit for az. so no uplift to eps from that. proposed acquisition is dilutive so sp will remain under pressure in 2021
                            0
                        • Underwhelming performance even after brexit deal and vax approval. Sight bump after brexit deal but nothing significant after over 10% decline
                          0
                          • Im not sure what everyone wad expecting? Its all been priced in long ago.
                            0
                          • an underperformer vis a vis rest of the market on brexit deal and vax. post acquisition announcement, the wind has gone out of azn
                            0
                        • 8500 in a weeks time
                          2
                          • nonsense
                            0
                          • Great news, AstraZeneca now been approved in UKI think India will approve this week to start the vaccination programme by New Year
                            2
                        • 7525p
                          0
                          • Dont understand why stocks dipping. The got so mich going for them
                            0
                            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.